<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<key-projects><projects><title>Assessment of histopathology practices in biomarker qualification</title><description>This project will adopt modern tissue imaging methods to the quantification of drug-induced injury to specific organs in appropriate animal models (e.g. incipient pancreas injury in Sprague-Dawley rats exposed to low doses of anti-diabetic drugs).</description>
<description>&lt;br&gt;This key project has been retired as CDER has created new measures and key projects for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research. &lt;/b&gt;</description>

<dictionary></dictionary><outcome></outcome><accomplishment></accomplishment><table><title></title><overall-status><briefing>ON HOLD</briefing><prior-briefing>ON HOLD</prior-briefing></overall-status><row><type></type><milestone-description>1. Develop concept paper</milestone-description><milestone-date>3/31/2010</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>3/31/2010</milestone-completion-date></row><row><type></type><milestone-description>2. Finalize research plan</milestone-description><milestone-date>4/15/2010</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>4/15/2010</milestone-completion-date></row><row><type></type><milestone-description>3. Submit protocol</milestone-description><milestone-date>4/22/2010</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>4/22/2010</milestone-completion-date></row><row><type></type><milestone-description>4. Initiate study</milestone-description><milestone-date>5/1/2010</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>5/1/2010</milestone-completion-date></row><row><type></type><milestone-description>5. Conduct interim analysis</milestone-description><milestone-date>7/15/2010</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>7/15/2010</milestone-completion-date></row><row><type></type><milestone-description>6. Complete study (1)</milestone-description><milestone-date>9/30/2010 &lt;i&gt;(4/30/2012)&lt;/i&gt;</milestone-date><milestone-status>Not Yet Started</milestone-status><milestone-completion-date></milestone-completion-date></row><row><type></type><milestone-description>7. Release study report (1)</milestone-description><milestone-date>12/31/2010 &lt;i&gt;(7/31/2012)&lt;/i&gt;</milestone-date><milestone-status>Not Yet Started</milestone-status><milestone-completion-date></milestone-completion-date></row><footnotes><note>(1) The dates in italics under the milestone due dates are revised milestone due dates which have been updated.</note></footnotes></table></projects><related-links><link><url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htm</url><text>FDA-TRACK CDER Dashboard</text></link></related-links></key-projects>
    






